Stryker Résultats passés

Passé contrôle des critères 5/6

Stryker a connu une croissance annuelle moyenne de ses bénéfices de 11.2%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en hausse à 13.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 9.3% par an. Le rendement des capitaux propres de Stryker est 17.8% et ses marges nettes sont de 16.3%.

Informations clés

11.2%

Taux de croissance des bénéfices

10.8%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie	8.9%
Taux de croissance des recettes	9.3%
Rendement des fonds propres	17.8%
Marge nette	16.3%
Dernière mise à jour des bénéfices	30 Sep 2024

Mises à jour récentes des performances passées

Recent updates

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Ventilation des recettes et des dépenses

Comment Stryker gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

NYSE:SYK Recettes, dépenses et bénéfices (USD Millions )
Date	Recettes	Les revenus	Dépenses G+A	Dépenses de R&D
30 Sep 24	21,974	3,590	7,327	1,457
30 Jun 24	21,389	3,448	7,206	1,433
31 Mar 24	20,963	3,361	7,051	1,416
31 Dec 23	20,498	3,165	6,943	1,387
30 Sep 23	19,885	2,585	6,690	1,364
30 Jun 23	19,455	2,709	6,494	1,367
31 Mar 23	18,952	2,627	6,278	1,372
31 Dec 22	18,449	2,358	6,114	1,367
30 Sep 22	17,948	2,457	6,014	1,372
30 Jun 22	17,629	2,079	5,925	1,322
31 Mar 22	17,430	2,015	5,929	1,281
31 Dec 21	17,108	1,994	5,752	1,235
30 Sep 21	16,669	1,900	5,525	1,159
30 Jun 21	16,246	2,083	5,297	1,095
31 Mar 21	14,716	1,408	4,900	1,018
31 Dec 20	14,351	1,599	4,759	984
30 Sep 20	14,220	1,756	4,766	983
30 Jun 20	14,070	1,601	4,824	987
31 Mar 20	14,956	2,164	4,995	1,000
31 Dec 19	14,884	2,083	4,968	971
30 Sep 19	14,549	3,426	4,970	938
30 Jun 19	14,204	3,550	4,914	913
31 Mar 19	13,876	3,522	4,864	883
31 Dec 18	13,601	3,553	4,808	862
30 Sep 18	13,276	1,236	4,687	846
30 Jun 18	13,040	1,080	4,556	823
31 Mar 18	12,730	1,019	4,484	799
31 Dec 17	12,444	1,020	4,380	787
30 Sep 17	12,130	1,779	4,239	771
30 Jun 17	11,957	1,700	4,167	757
31 Mar 17	11,785	1,689	4,076	748
31 Dec 16	11,325	1,647	3,941	715
30 Sep 16	10,883	1,659	3,828	690
30 Jun 16	10,470	1,605	3,703	661
31 Mar 16	10,062	1,617	3,591	632
31 Dec 15	9,946	1,439	3,511	625
30 Sep 15	9,849	1,177	3,445	614
30 Jun 15	9,818	933	3,417	612
31 Mar 15	9,749	669	3,381	616
31 Dec 14	9,675	515	3,356	614
30 Sep 14	9,525	641	2,851	600
30 Jun 14	9,287	687	3,147	583
31 Mar 14	9,136	772	3,305	557
31 Dec 13	9,021	1,006	3,345	536

Des revenus de qualité: SYK a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de SYK sont plus élevées que l'année dernière SYK. (16.3%) sont plus élevées que l'année dernière (13%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de SYK ont augmenté de 11.2% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de SYK au cours de l'année écoulée ( 38.9% ) dépasse sa moyenne sur 5 ans ( 11.2% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices SYK au cours de l'année écoulée ( 38.9% ) a dépassé celle du secteur Medical Equipment 11.7%.

Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de SYK ( 17.8% ) est considéré comme faible.

Stryker Résultats passés

Passé contrôle des critères 5/6

Informations clés

Mises à jour récentes des performances passées

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Recent updates

Chairman exercised options and sold US$43m worth of stock

Stryker Launches Next Generation of SurgiCount+ to Help Improve the Standard of Care in Hospitals for Sponge Management and Blood Loss Assessment

Independent Director recently sold US$84m worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock